Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Self-reactive B cells in the GALT are actively curtailed to prevent gut inflammation
Ashima Shukla, … , John R. Apgar, Robert C. Rickert
Ashima Shukla, … , John R. Apgar, Robert C. Rickert
Published July 23, 2019
Citation Information: JCI Insight. 2019;4(16):e130621. https://doi.org/10.1172/jci.insight.130621.
View: Text | PDF
Research Article Immunology Inflammation

Self-reactive B cells in the GALT are actively curtailed to prevent gut inflammation

  • Text
  • PDF
Abstract

Immune homeostasis in the gut-associated lymphoid tissues (GALT) is critical to prevent the development of inadvertent pathologies. B cells, as the producers of antibodies and cytokines, play an important role in maintaining the GALT homeostasis. However, the mechanism by which B cells specifically direct their responses toward non-self-antigens and become ignorant to self-antigens in the GALT is not known. Therefore, we developed what we believe to be a novel mouse model by expressing duck egg lysozyme (DEL) in gut epithelial cells in presence of HEL-reactive B cells. Notably, we observed a transient activation and rapid deletion of self-reactive B cells in Peyer’s patches and mesenteric lymph nodes upon self-antigen exposure. The survival of self-reactive B cells upon exposure to their self-antigen was partially rescued by blocking receptor editing but could be completely rescued by stronger survival signal, such as ectopic expression of BCL2. Importantly, rescuing the self-reactive B cells promoted production of autoantibodies and gut inflammation. Mechanistically, we identify a specific activation of TGF-β signaling in self-reactive B cells in the gut and a critical role of this pathway in maintaining peripheral tolerance. Collectively, our studies describe functional consequences and the fate of self-reactive B cells in GALT and provide potentially novel mechanistic insights governing self-tolerance of B cells in the gut.

Authors

Ashima Shukla, Cindi Chen, Julia Jellusova, Charlotte R. Leung, Elaine Kao, Numana Bhat, Wai W. Lin, John R. Apgar, Robert C. Rickert

×

Figure 6

Deregulation of B cell tolerance in gut leads to IBD-like disease.

Options: View larger image (or click on image) Download as PowerPoint
Deregulation of B cell tolerance in gut leads to IBD-like disease.
(A) F...
(A) Flow contour plot showing the IgG1- and IgA-switched HEL-specific cells in the PPs and graph showing the frequency of HEL-specific IgA-switched cells in the spleens, pLNs, mLNs, and PPs of RVillincre+(Bcl2) and RVillincre+mDELloxp (Bcl2) mice. The MFI of HEL-specific anti-IgA, anti-IgG1, and IgG2c (B) in serum and (C) in fecal extracts of RVillincre+(Bcl2) and RVillincre+mDELloxp (Bcl2) mice. (D) H&E staining of small and large intestine showing infiltration and inflammation in RVillincre+mDELloxp (Bcl2) mice (original magnification, ×5 [muscularis]; ×20 [inflammation and villus]). (E) The gut histological scoring of n = 6 and n = 7, respectively, per group of RVillincre+ (Bcl2) and RVillincre+mDELloxp (Bcl2) mice.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts